Featured Publication Blood-brain barrier disruption and sustained systemic inflammation in individuals with long COVID-associated cognitive impairment Read about publication
Neurology Undergraduate Medical Education: A Scoping Review 2025 AcademicClinical FutureNeuro Authors Susan Byrne Norman Delanty
Second-Line Medications for Women Aged 10 to 50 Years With Idiopathic Generalized Epilepsy 2025 TherapeuticsAcademicClinicalEpilepsy FutureNeuro Authors Norman Delanty
Challenges and solutions to complex data governance issues in cross-national, cross-sectoral, multidisciplinary real world health research: a descriptive overview 2025 Digital HealthTherapeuticsAcademicClinicalIndustryMotor Neuron Disease/ ALS FutureNeuro Authors Orla Hardiman
Feasibility and usability evaluation of a gamified fatigue management mobile application for persons with Multiple Sclerosis 2025 Digital HealthAcademicClinicalMultiple Sclerosis Lay Summary FutureNeuro Authors Guido Giunti
Polygenic risk scores for eGFR are associated with age at kidney failure 2025 DiagnosticsAcademicClinicalGenomics FutureNeuro Authors Gianpiero Cavalleri
Evaluating the evidence behind multidisciplinary roles for a multiple sclerosis unit: A systematic literature review 2025 TherapeuticsAcademicClinicalMultiple Sclerosis Lay Summary FutureNeuro Authors Hugh Kearney Guido Giunti
Developmental stage of childhood trauma exposure and markers of inflammation at age 24 2025 DiagnosticsAcademicClinicalMental Health Lay Summary FutureNeuro Authors David Cotter Mary Cannon
Effectiveness During 12-Month Adjunctive Brivaracetam Treatment in Patients with Focal-Onset Seizures in a Real-Life Setting: A Prospective, Observational Study in Europe 2025 TherapeuticsAcademicClinicalEpilepsy Lay Summary FutureNeuro Authors Colin Doherty
An overview of the value of mTOR inhibitors to the treatment of epilepsy: the evidence to date 2025 TherapeuticsClinicalEpilepsy FutureNeuro Authors Norman Delanty
The use of steroids in adult epilepsy: A systematic review 2025 TherapeuticsClinicalEpilepsy FutureNeuro Authors Colin Doherty
An overview of the value of mTOR inhibitors to the treatment of epilepsy: the evidence to date. 2025 TherapeuticsAcademicClinicalEpilepsy FutureNeuro Authors Norman Delanty
The impact of a secondary, rare, non-pathogenic PKD1 variant on disease progression in autosomal dominant polycystic kidney disease. 2025 DiagnosticsAcademicClinicalGenomics FutureNeuro Authors Gianpiero Cavalleri